Dr Adrian Traeger
PhD, BSc Hons I, MPhty
Senior Research Fellow, Sydney University Robinson Fellow
Dr. Adrian Traeger is an emerging leader in the field of back pain research, currently serving as a University of Sydney Robinson Fellow (2023-2026). Adrian was awarded his PhD in 2017 and since then has rapidly established himself as a leading expert, particularly in patient-provider communication and the overuse of low-value healthcare. His work has been published in high impact journals such as BMJ, JAMA, and JAMA Internal Medicine.
​
Dr. Traeger has secured over AUD$14.2 million in competitive grant funding and leads a multidisciplinary team focused on improving healthcare delivery and reducing unnecessary and low value healthcare interventions. He has an impressive publication record with 104 papers, 57 of which he is the first, second, or last author.
​
Recognised globally, he was ranked the #1 postdoctoral researcher in back pain by Expertscape and received the Australian Pain Society Rising Star Award in 2022. His research has significantly influenced clinical guidelines and care standards in multiple countries, and his decision tool, ‘PICKUP,’ is widely used by healthcare professionals.
​
He collaborates extensively with clinicians, service providers, consumers throughout the New South Wales local health district network and has established links with international researchers from various institutions such as the University of Cambridge and Northwestern University. His work has garnered substantial media attention, featuring on ABC 4 Corners, Health Report and Channel 7 News.
KEY PUBLICATIONS​
Care for low back pain: can health systems deliver? Bulletin of the World Health Organisation
Spinal cord stimulation for low back pain Cochrane Database for Systematic Reviews
Key Research Projects
NUDGED (Chief Investigator)
The NUDG-ED trial is a pioneering study designed to reduce low-value care for back pain in emergency departments through behavioral nudges. This 2×2 factorial, open-label, before-after, cluster randomized controlled trial involves eight emergency department sites in Sydney. Participants include emergency physicians and adult patients with musculoskeletal back pain. The trial tests four interventions: patient nudges, clinician nudges, both, or no nudge (control). Patient nudges involve posters in multiple languages (English, Arabic, Chinese, and Vietnamese) to correct misconceptions about imaging and opioid use for back pain. Clinician nudges are electronic alerts triggered when prescribing opioids or imaging, advising against these practices without red flags and suggesting evidence-based alternatives. The primary outcome is the proportion of emergency department encounters for back pain where non-indicated lumbar imaging or opioids are prescribed at discharge. This study aims to improve care quality by reducing unnecessary interventions and promoting better treatment practices.
RECITAL Trial (Principal Investigator)
The RECITAL Trial addresses the growing burden on outpatient fracture clinics, which face increased demand for follow-ups and limited resources, resulting in long wait times and productivity losses for patients and carers. While virtual fracture clinics have been proposed as a solution for managing simple fractures, comprehensive evaluations of their safety, effectiveness, and cost-effectiveness are still needed. This prospective, two-arm, parallel group randomized controlled trial aims to determine if virtual care is non-inferior to in-person care for patients with simple fractures. The study uses a non-inferiority design and includes nested economic and process evaluations, along with semi-structured qualitative interviews with a subset of patients. The primary objective is to assess whether virtual care results in non-inferior physical function outcomes at 12 weeks, measured by the Patient-Specific Functional Scale (PSFS). Secondary objectives include comparing pain levels, health-related quality of life, patient experiences, cost-effectiveness, healthcare utilization, medication use, and safety (adverse events) at 6 and 12 weeks. Participants referred to Royal Prince Alfred’s virtual fracture clinic will be screened and, if eligible and willing, randomized to either virtual or in-person follow-up care. The intervention group will receive standard fracture management information and have follow-ups via phone or video calls with a physiotherapist. The control group will attend in-person clinic appointments with an orthopaedic doctor. Participants will complete a series of surveys as part of their clinical care.